Latest News
The European ETF industry enjoyed healthy inflows over the course of April despite the market turmoil caused by the announcement of new tariff regimes by the U.S.
Via Talk Markets · June 7, 2025
The indicator detected a recession in March 2024, stayed above the threshold thereafter, so the implication is that we are currently the same recession.
Via Talk Markets · June 7, 2025
INTERPUBLIC GROUP (NYSE:IPG) offers a strong 5.43% dividend yield with a reliable payout history, solid profitability, and reasonable valuation, making it a candidate for dividend investors.
Via Chartmill · June 7, 2025
HALOZYME THERAPEUTICS (NASDAQ:HALO) offers strong growth, solid profitability, and an attractive valuation, making it a standout in the biotech sector for investors seeking affordable growth opportunities.
Via Chartmill · June 7, 2025
MICROVAST HOLDINGS (NASDAQ:MVST) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a stock to watch for momentum investors.
Via Chartmill · June 7, 2025
April results were revised down to 147K while March numbers have been reduced by over 100,000 the last two months to 120K.
Via Talk Markets · June 7, 2025
FOX CORP (NASDAQ:FOXA) appears undervalued with strong profitability, solid financial health, and reasonable growth, making it a potential pick for value investors.
Via Chartmill · June 7, 2025
GLOBUS MEDICAL (NYSE:GMED) is a strong growth stock with reasonable valuation, solid profitability, and a healthy balance sheet, making it an attractive option for investors seeking growth at a fair price.
Via Chartmill · June 7, 2025
VIPSHOP HOLDINGS (NYSE:VIPS) offers growth at a reasonable price, with strong profitability, low debt, and a PEG of 0.36. A potential GARP pick for long-term investors.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
CATALYST PHARMACEUTICALS (CPRX) offers strong growth, solid profitability, and an attractive valuation, making it a standout in biotech.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
META PLATFORMS (NASDAQ:META) meets key quality investing criteria with strong growth, high ROIC, and solid financials, making it a stock worth considering for long-term investors.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
ALTRIA GROUP INC (NYSE:MO) offers a high 6.86% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
BRIGHTSPRING HEALTH SERVICES (NASDAQ:BTSG) shows strong technicals and a high-quality setup, making it a stock to watch for potential breakout traders.
Via Chartmill · June 7, 2025
Coupang is executing its way to become the Amazon of South Korea.
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
SPROUTS FARMERS MARKET (NASDAQ:SFM) shows strong earnings momentum, expanding margins, and a bullish technical setup, making it a candidate for growth investors.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
WAYSTAR HOLDING CORP (NASDAQ:WAY) shows strong earnings momentum and a solid technical setup, making it a candidate for high-growth investors. The stock has rising EPS, expanding margins, and bullish price trends.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025
TRAVEL + LEISURE CO (NYSE:TNL) appears undervalued with strong liquidity, stable profitability, and a high dividend yield. Future earnings growth could drive further upside.
Via Chartmill · June 7, 2025
Via The Motley Fool · June 7, 2025
XPEL INC (NASDAQ:XPEL) offers strong growth, solid profitability, and reasonable valuation, making it a candidate for GARP investors following Peter Lynch’s strategy.
Via Chartmill · June 7, 2025
Each of the index's highest-yielding names has its own unique story right now.
Via The Motley Fool · June 7, 2025
In a heated debate on Piers Morgan Uncensored, Scott Galloway criticized Elon Musk's personal behavior while Kevin O'Leary defended his technological achievements, with Galloway saying, "I think the two of you are more impressed with Mr. Musk than I am."
Via Benzinga · June 7, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout opportunity.
Via Chartmill · June 7, 2025
All of the factors align for this company to split its shares, but it's a buy no matter what.
Via The Motley Fool · June 7, 2025
Are you ready for C-3PO to ring your doorbell?
Via Talk Markets · June 7, 2025
Via The Motley Fool · June 7, 2025